Cover Image
市場調查報告書

胰島素幫浦(體外式)的全球市場

Insulin Pumps (External)

出版商 Global Industry Analysts, Inc. 商品編碼 138674
出版日期 內容資訊 英文 135 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
胰島素幫浦(體外式)的全球市場 Insulin Pumps (External)
出版日期: 2014年03月01日 內容資訊: 英文 135 Pages
簡介

本報告提供全球胰島素幫浦(體外式)市場相關調查,提供各地區的總括性趨勢,彙整2013∼2020年的預測,加入此市場的企業簡介,為您概述為以下內容。

第1章 簡介,調查方法,產品定義

第2章 摘要整理

  • 產業概要
    • 胰島素幫浦:概要
    • 美國:最大市場
    • 歐洲:具有莫大潛在性的市場
    • 糖尿病罹患率的上升:推動因素
  • 競爭分析
    • 胰島素幫浦市場:注目的市場
    • 各製造廠商胰島素幫浦比較
    • 貼片幫浦市場上的競爭激烈化
    • 對新加入廠商而言的嚴苛地盤
  • 市場趨勢與課題
    • 智慧型幫浦的興起
    • 人工胰臟系統:未來的糖尿病護理
    • 第二型糖尿病:具有莫大可能性的市場
    • 老年人層的糖尿病風險為胰島素幫浦帶來機會
    • 警告性肥胖人口的增加:糖尿病護理的商務案例其他
  • 課題
    • 埋入式胰島素幫浦
    • 胰島素幫浦訓練
    • 複雜的胰島素幫浦軟體對老年人而言難以使用
    • 其他的胰島素給藥技術持續競爭
    • 未診斷的糖尿病
    • Lantus:對胰島素幫浦廠商而言的威脅
  • 糖尿病發病率和罹患率
  • 糖尿病和胰島素:概要
  • 產品概要
  • 產品創新/簡介
  • 近幾年的產業的動向
  • 主要企業
    • Animas Corp.
    • Debiotech S.A.
    • F. Hoffmann-La Roche, Ltd.
    • Insulet Corp.
    • Medtronic
    • Medtronic Diabetes
    • Sooil Development Co. Ltd.
    • Tandem Diabetes Care Inc.
    • Valeritas Inc.
    • Ypsomed Holding AG
  • 全球市場預測

第3章 市場

  • 美國
  • 加拿大
  • 日本
  • 歐洲
  • 亞太地區
  • 南美
  • 其他

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: MCP-1511

This report analyzes the worldwide markets for Insulin Pumps (External) in US$ Million. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2013 through 2020. Also, a seven-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. The report profiles 13 companies including many key and niche players such as -

Animas Corp.
Debiotech S.A
F. Hoffmann-La Roche, Ltd.
Insulet Corp.
Medtronic

Table of Contents

I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS

  • Study Reliability and Reporting Limitations
  • Disclaimers
  • Data Interpretation & Reporting Level
    • Quantitative Techniques & Analytics
  • Product Definitions and Scope of Study

II. EXECUTIVE SUMMARY

1. INDUSTRY OVERVIEW

  • Insulin Pumps: A Prelude
  • The United States - The Largest Market
  • Europe - A Market with Vast Potential
  • Rising Incidence of Diabetes - The Driving Factor
    • Table 1: Worldwide Prevalence of Diabetes Mellitus by Region: 2013 & 2035 P (includes corresponding Graph/Chart)

2. COMPETITIVE ANALYSIS

  • Insulin Pumps Market - Set for Interesting Road Ahead
    • Table 2: Global External Insulin Pumps Market by Leading Players (2013): Percentage Market Share Breakdown of Value Sales for Medtronic, Insulet, Roche, J&J (Animas), and Others (includes corresponding Graph/Chart)
    • Table 3: Global Market for External Insulin Pumps by Leading Players (2014E): Percentage Share Breakdown of Value Sales for Medtronic, Insulet, Roche, J&J (Animas), Tandem and Others (includes corresponding Graph/Chart)
  • Comparison of Select Insulin Pumps by Manufacturer
  • Competition Heats Up in the Patch Pumps Market
  • Tough Ground for New Entrants

3. MARKET TRENDS AND ISSUES

  • The Rise of Smart Pumps - A Major Game Changer
  • Artificial Pancreas System (APS) - The Future of Diabetes Care
  • Type II Diabetes - A Market with Significant Potential
  • The Risk of Diabetes in Aging Populace Presents Opportunities for Insulin Pumps
    • Table 4: Global Population Statistics for the 65+ Age Group (Male & Female) for Major Countries/Regions: 2013E (includes corresponding Graph/Chart)
  • Alarming Rise in Obesity - A Business Case for Diabetes Care
    • Table 5: Obesity Rates (%) in OECD Countries (includes corresponding Graph/Chart)
    • Table 6: Obese and Overweight & Obese Population in the World (2013): Percentage Share Breakdown by Region for US, European Union, and Rest of World (includes corresponding Graph/Chart)
  • Diabetes in Developing Countries to Expand Opportunities
  • Innovative Features Spruce Up the Market for Insulin Pumps
  • Patch Pumps Gain Manufacturer Attention
  • ICR: A Key Factor to Success
  • Expiry of Warranty Provides New Opportunities to Insulin Pump Makers
  • Teenagers Outdo Adults in Controlling Diabetes
  • Customer Satisfaction: Crucial to Stay Competitive

4. CHALLENGES

  • Implantable Insulin Pumps - A Potential Threat to External Insulin Pumps
  • Insulin Pump Training - Not Receiving Adequate Attention
  • Complicated Insulin Pump Software Makes Pump Use Difficult for the Aged
  • Competition from Other Insulin Delivery Technologies Continues
  • Undiagnosed Diabetes - A Key Challenge
  • Lantus: A Threat to Insulin Pump Manufacturers

5. DIABETES- INCIDENCE AND PREVALENCE

    • Table 7: Global Diabetic Population by Region (2013 & 2035) (includes corresponding Graph/Chart)
    • Table 8: Top Ten Diabetic Countries (2013) by Number of Individuals with Diabetes (includes corresponding Graph/Chart)
    • Table 9: Top Ten Countries by Diabetic Population (2035) (includes corresponding Graph/Chart)
  • Diabetes - Assessing the Economic Burden
    • Table 10: Diabetes Related Healthcare Expenditure by Region: 2013 (In US$ billion) (includes corresponding Graph/Chart)
  • Diabetes Mellitus Cases Worldwide - A Demographic Analysis by Geographic Region
  • North America
    • United States
    • Canada
    • Mexico
    • Table 11: Prevalence of Diabetes Mellitus in North America (2035 P): Breakdown by Country, Age Group, and Gender (In Thousand People & %) (includes corresponding Graph/Chart)
  • Europe
    • Table 12: Prevalence of Diabetes Mellitus in Europe (2035P): Breakdown by Country, Age Group, and Gender (In Thousand People & %)
  • Asia-Pacific
    • Southeast Asian Region
    • Western Pacific Region
  • South & Central America
    • Type-1 Diabetes
    • Type-2 Diabetes

6. DIABETES & INSULIN - AN ABSTRACT

  • Diabetes - A Fatal Disease
  • Risk Factors for Diabetes
  • Types of Diabetes
  • Long Term Complications of Diabetes
  • Testing Sugar Levels: Easy and Accurate
  • Insulin
  • Pancreas: The Main Source of Insulin in Human Body
  • Types of Insulin
    • Types of Insulin & Onset of Action
  • Goal of Insulin Therapy
  • Insulin Delivery Systems
    • Table 13: Global Insulin Delivery Devices Market by Leading Players (2013): Percentage Market Share Breakdown for Medtronic, Novo Nordisk, Sanofi and Others (includes corresponding Graph/Chart)
  • a. Syringes
  • b. Insulin Pens
  • c. Jet Injectors
  • d. Tablets
  • e. External Insulin Pumps
  • f. Artificial Pancreas
  • Insulin Delivery Technologies

7. PRODUCT OVERVIEW

  • Evolution of Insulin Pumps
  • Insulin Pump - A Replica of Pancreas
  • Advantages
  • More Accurate and Consistent
  • Enhances Blood Sugar Control in Pediatric Patients
  • Adjusting Time Zones While Traveling
  • Improves Quality of Life
  • Patient Convenience
  • Components of Insulin Pump
  • How Does an Insulin Pump Work?
  • Value-added Features of Modern Insulin Pumps
    • Bolus Calculators
    • Insulin On Board
    • Customized Alarms
    • Touch Bolus
    • Interface to PCs
    • Others
  • Insulin Pump Delivery Rates
  • Guidelines for Insulin Pump Usage
  • Disadvantages/Risks Involved in the Usage of Insulin Pumps
  • High Cost
  • High Involvement
  • Diabetic Ketoacidosis Risk
  • Glucose Testing at Regular Intervals
  • Regular Rotation of Infusion Set
  • Carrying Back-up Kit
  • Regular Refilling of Pump

8. PRODUCT INNOVATIONS/INTRODUCTIONS

  • Debiotech to Unveil Jewel Pump 2
  • Cellnovo Introduces Novel Insulin Pump System
  • J&J Introduces Animas Vibe in Canada
  • Tandem Introduces New Insulin Pump, t:slim, with a Touch Screen

9. RECENT INDUSTRY ACTIVITY

  • Roche and Novo Nordisk Team Up for Insulin Pump Cartridge
  • Medtronic Secures FDA Approval for MiniMed 530G
  • LifeScan Acquires Calibra Medical
  • Mediq Takes Over Diabetes Specialty Center
  • Indutrade to Acquire Rubin Medical
  • Cellnovo Obtains CE Mark for Patch Pump
  • Asante Secures 510 (K) Approval
  • Medtronic and Bayer HealthCare Expand Collaboration to Cover US Market
  • Insulet Acquires Neighborhood Diabetes
  • JDRF Enters into Partnership with Animas
  • JDRF Collaborates with BD
  • Insulet Inks Exclusive Distribution Agreement with Ypsomed
  • Roche Takes Over Medingo

10. FOCUS ON SELECT KEY PLAYERS

  • Animas Corp. (USA)
  • Debiotech S.A. (Switzerland)
  • F. Hoffmann-La Roche, Ltd. (Switzerland)
  • Insulet Corp. (USA)
  • Medtronic (USA)
  • Medtronic Diabetes (USA)
  • Sooil Development Co. Ltd. (Korea)
  • Tandem Diabetes Care Inc. (USA)
  • Valeritas Inc. (US)
  • Ypsomed Holding AG (Switzerland)

11. GLOBAL MARKET PERSPECTIVE

    • Table 14: World Recent Past, Current & Future Analysis for Insulin Pumps (External) by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (exc. Japan), Latin America, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2013 through 2020 (includes corresponding Graph/Chart)
    • Table 15: World Historic Review for Insulin Pumps (External) by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (exc. Japan), Latin America, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2006 through 2012 (includes corresponding Graph/Chart)
    • Table 16: World 15-Year Perspective for Insulin Pumps (External) by Geographic Region - Percentage Breakdown of Value Sales for US, Canada, Japan, Europe, Asia-Pacific (exc. Japan), Latin America, and Rest of World Markets for Years 2006, 2014 & 2020 (includes corresponding Graph/Chart)

III. MARKET

1. THE UNITED STATES

  • A. Market Analysis
    • Table 17: US Market Proliferation of Insulin Pumps in Type I Diabetes Treatment (2010-2017P) (includes corresponding Graph/Chart)
    • Surging Diabetic Population Spurs Demand
    • Table 18: US Diabetics Population (2010-2017): Percentage Population with Diagnosed and Undiagnosed Diabetes (includes corresponding Graph/Chart)
    • Table 19: US Market for Diabetes Management (2014E & 2017P): Percentage Share Breakdown by Treatment Type (includes corresponding Graph/Chart)
    • Table 20: Diabetes Prevalence by Ethnicity (includes corresponding Graph/Chart)
    • Table 21: US Diabetes Prevalence (in 000's) for 2010-2017P (includes corresponding Graph/Chart)
    • Table 22: Diabetes Prevalence in the US by Type: 2013 (includes corresponding Graph/Chart)
    • Artificial Pancreas System (APS): The Future of Diabetes Management
      • Select Ongoing Clinical Studies on Artificial Pancreas Technology
    • Competitive Scenario
    • Table 23: The US Insulin Pumps Market by Leading Players (2013): Percentage Market Share Breakdown of Value Sales for Medtronic, Animas (J&J), Insulet, and Others (includes corresponding Graph/Chart)
    • Table 24: Major Insulin Pump Systems Available in the US
    • Reimbursements
    • Regulatory Scenario
      • FDA Announces a New Mandate for Manufacturing Companies
    • Strategic Corporate Developments
    • Key Players
  • B. Market Analytics
    • Table 25: The US Recent Past, Current & Future Analysis for Insulin Pumps (External) Market Analyzed with Annual Sales Figures in US$ Thousands for Years 2013 through 2020 (includes corresponding Graph/Chart)
    • Table 26: The US Historic Review for Insulin Pumps (External) Market Analyzed with Annual Sales Figures in US$ Thousands for Years 2006 through 2012 (includes corresponding Graph/Chart)

2. CANADA

  • A. Market Analysis
    • Product Launch
  • B. Market Analytics
    • Table 27: Canadian Recent Past, Current & Future Analysis for Insulin Pumps (External) Market Analyzed with Annual Sales Figures in US$ Thousands for Years 2013 through 2020 (includes corresponding Graph/Chart)
    • Table 28: Canadian Historic Review for Insulin Pumps (External) Market Analyzed with Annual Sales Figures in US$ Thousands for Years 2006 through 2012 (includes corresponding Graph/Chart)

3. JAPAN

  • Market Analysis
    • Table 29: Japanese Recent Past, Current & Future Analysis for Insulin Pumps (External) Market Analyzed with Annual Sales Figures in US$ Thousands for Years 2013 through 2020 (includes corresponding Graph/Chart)
    • Table 30: Japanese Historic Review for Insulin Pumps (External) Market Analyzed with Annual Sales Figures in US$ Thousands for Years 2006 through 2012 (includes corresponding Graph/Chart)

4. EUROPE

  • A. Market Analysis
    • Regional Scenario
    • Diabetes Prevalence in Europe
    • Table 31: Diabetes Mellitus in Europe (2013 & 2035P): Percentage Breakdown of Prevalence in Population by Country (includes corresponding Graph/Chart)
    • Table 32: Percentage of Population with Diabetes and Prevalence of Diabetes in the EU (2009-2015) (includes corresponding Graph/Chart)
    • Strategic Corporate Developments
    • Select Key Players
  • B. Market Analytics
    • Table 33: European Recent Past, Current & Future Analysis for Insulin Pumps (External) by Geographic Region - France, Germany, Italy, UK, Spain, and Rest of Europe Markets Independently Analyzed with Annual Sales Figures in US$ Thousands for Years 2013 through 2020 (includes corresponding Graph/Chart)
    • Table 34: European Historic Review for Insulin Pumps (External) by Geographic Region - France, Germany, Italy, UK, Spain, and Rest of Europe Markets Independently Analyzed with Annual Sales Figures in US$ Thousands for Years 2006 through 2012 (includes corresponding Graph/Chart)
    • Table 35: European 15-Year Perspective for Insulin Pumps (External) by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, and Rest of Europe Markets for Years 2006, 2014 & 2020 (includes corresponding Graph/Chart)

4a. FRANCE

  • Market Analysis
    • Table 36: French Recent Past, Current & Future Analysis for Insulin Pumps (External) Market Analyzed with Annual Sales Figures in US$ Thousands for Years 2013 through 2020 (includes corresponding Graph/Chart)
    • Table 37: French Historic Review for Insulin Pumps (External) Market Analyzed with Annual Sales Figures in US$ Thousands for Years 2006 through 2012 (includes corresponding Graph/Chart)

4b. GERMANY

  • Market Analysis
    • Table 38: German Recent Past, Current & Future Analysis for Insulin Pumps (External) Market Analyzed with Annual Sales Figures in US$ Thousands for Years 2013 through 2020 (includes corresponding Graph/Chart)
    • Table 39: German Historic Review for Insulin Pumps (External) Market Analyzed with Annual Sales Figures in US$ Thousands for Years 2006 through 2012 (includes corresponding Graph/Chart)

4c. ITALY

  • Market Analysis
    • Table 40: Italian Recent Past, Current & Future Analysis for Insulin Pumps (External) Market Analyzed with Annual Sales Figures in US$ Thousands for Years 2013 through 2020 (includes corresponding Graph/Chart)
    • Table 41: Italian Historic Review for Insulin Pumps (External) Market Analyzed with Annual Sales Figures in US$ Thousands for Years 2006 through 2012 (includes corresponding Graph/Chart)

4d. THE UNITED KINGDOM

  • A. Market Analysis
    • INPUT (The Insulin Pump Therapy Group)
    • NICE (National Institute of Clinical Excellence)
    • Product Launch
  • B. Market Analytics
    • Table 42: The UK Recent Past, Current & Future Analysis for Insulin Pumps (External) Market Analyzed with Annual Sales Figures in US$ Thousands for Years 2013 through 2020 (includes corresponding Graph/Chart)
    • Table 43: The UK Historic Review for Insulin Pumps (External) Market Analyzed with Annual Sales Figures in US$ Thousands for Years 2006 through 2012 (includes corresponding Graph/Chart)

4e. SPAIN

  • Market Analysis
    • Table 44: Spanish Recent Past, Current & Future Analysis for Insulin Pumps (External) Market Analyzed with Annual Sales Figures in US$ Thousands for Years 2013 through 2020 (includes corresponding Graph/Chart)
    • Table 45: Spanish Historic Review for Insulin Pumps (External) Market Analyzed with Annual Sales Figures in US$ Thousands for Years 2006 through 2012 (includes corresponding Graph/Chart)

4f. REST OF EUROPE

  • A. Market Analysis
    • Russia
    • Strategic Corporate Developments
  • B. Market Analytics
    • Table 46: Rest of European Recent Past, Current & Future Analysis for Insulin Pumps (External) Market Analyzed with Annual Sales Figures in US$ Thousands for Years 2013 through 2020 (includes corresponding Graph/Chart)
    • Table 47: Rest of European Historic Review for Insulin Pumps (External) Market Analyzed with Annual Sales Figures in US$ Thousands for Years 2006 through 2012 (includes corresponding Graph/Chart)

5. ASIA-PACIFIC

  • A. Market Analysis
    • Table 48: Diabetes Mellitus in Asia-Pacific (2013 & 2035 P): Percentage Breakdown of Prevalence by Select Countries (includes corresponding Graph/Chart)
    • Review of Select Markets
      • India
      • Diabetes Scenario
      • Insulin Pumps Gather Momentum
      • Medtronic: The Undisputed Market Leader
      • Diabetic Epidemic Spurs Indian Market
      • China
      • Overview
      • Competition
      • China: An Untapped Goldmine
    • Key Player
  • B. Market Analytics
    • Table 49: Asia-Pacific Recent Past, Current & Future Analysis for Insulin Pumps (External) Market Analyzed with Annual Sales Figures in US$ Thousands for Years 2013 through 2020 (includes corresponding Graph/Chart)
    • Table 50: Asia-Pacific Historic Review for Insulin Pumps (External) Market Analyzed with Annual Sales Figures in US$ Thousands for Years 2006 through 2012 (includes corresponding Graph/Chart)

6. LATIN AMERICA

  • A. Market Analysis
    • Brazil
  • B. Market Analytics
    • Table 51: Latin American Recent Past, Current & Future Analysis for Insulin Pumps (External) Market Analyzed with Annual Sales Figures in US$ Thousands for Years 2013 through 2020 (includes corresponding Graph/Chart)
    • Table 52: Latin American Historic Review for Insulin Pumps (External) Market Analyzed with Annual Sales Figures in US$ Thousands for Years 2006 through 2012 (includes corresponding Graph/Chart)

7. REST OF WORLD

  • A. Market Analysis
    • UAE
      • Demand for Insulin Pumps Grows Strongly in the UAE
    • Product Launch
  • B. Market Analytics
    • Table 53: Rest of World Recent Past, Current & Future Analysis for Insulin Pumps (External) Market Analyzed with Annual Sales Figures in US$ Thousands for Years 2013 through 2020 (includes corresponding Graph/Chart)
    • Table 54: Rest of World Historic Review for Insulin Pumps (External) Market Analyzed with Annual Sales Figures in US$ Thousands for Years 2006 through 2012 (includes corresponding Graph/Chart)
Back to Top